Iceland· IS-EU/1/02/246/001-003
Carbaglu
A carglumic acid product containing carglumic acid, registered in Iceland by Recordati Rare Diseases*. The same ATC class is registered in 16 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Carglumic acid is registered in 16 of 19 countries.
Countries holding a registration under ATC A16AA05 (carglumic acid), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 9 of them publish a price we can compare per daily dose
Carglumic acid · ATC A16AA05
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of carglumic acid costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Carglumic acid · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- IT Italy$92.77
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Carglumic acid
- Manufacturer
- Recordati Rare Diseases*
- Country
- Iceland (IS)
- ATC code
- A16AA05
- ATC class
- Carglumic acid
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 2
2 priced- ean01488960 stk x1 glasISK 490995
- ean0241125 stk x1 glasISK 74604
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Carglumic acid in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCARBAGLURecordati Rare Diseases, Puteaux
- ItalyACIDO CARGLUMICO WAYMADEWAYMADE B.V.
- SpainACIDO CARGLUMICO TILLOMED 200 MG COMPRIMIDOS DISPERSABLES EFGLaboratorios Tillomed Spain S.L.U
- FinlandCarbagluRecordati Rare Diseases
- FranceACIDE CARGLUMIQUE TILLOMED 200 mg, comprimé dispersible sécableTILLOMED PHARMA (ALLEMAGNE)
- United StatesCarbagluRecordati Rare Diseases
- NetherlandsCarbaglu 200 mg, dispergeerbare tablettenOrphan Europe SARL
- SwedenCarbaglu 200 mg Dispergerbar tablettRecordati Rare Diseases
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Carglumsäure Waymade
- Czechia · Carglumic Acid
- Germany · Carglumsäure Waymade, Carglumsäure Zentiva
- Denmark · Cargluminsyre
- Spain · Ácido Carglúmico, Ácido Carglúmico Tillomed
- Finland · Karglumiinihappo Waymade
- France · Acide Carglumique Tillomed, Acide Carglumique Waymade
- United Kingdom (Northern Ireland) · Carglumic Acid Waymade
- Greece · Carglumic Acid, Carglumic Acid Tillomed
- Italy · Acido Carglumico Waymade
- Liechtenstein · Carbaglu, Ucedane
- Netherlands · Carglumaatzuur Tillomed, Carglumaatzuur Waymade
- Norway · Carbaglu, Kargluminsyre Waymade
- Poland · Kwas Kargluminowy
- Portugal · Ácido Carglúmico, Ácido Carglúmico Waymade
- Sweden · Kargluminsyra Waymade
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/00c74385-f3f7-455e-a2ec-c1db4f004819 GET /v1/drugs/00c74385-f3f7-455e-a2ec-c1db4f004819?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Dreifitafla",
"source": "lyfjastofnun",
"atc_raw": "A16AA05",
"marketed": true,
"strength": "200 mg",
"ma_number": "EU/1/02/246/001-003",
"substance": "Carglumic acid",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga í innkirtla- og efnaskiptasjúkdómum og sérfræðinga í taugasjúkdómum.",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "37669"
}See everything about carglumic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.